AI assistant
Sending…
TISSUE REGENIX GROUP PLC — Major Shareholding Notification 2015
May 21, 2015
7973_mrq_2015-05-21_c34c8b84-3258-4320-aa65-2f091aef4087.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 8935N
Tissue Regenix Group PLC
21 May 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Tissue Regenix Group plc | |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights | X | |||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
| An event changing the breakdown of voting rights | ||||
| Other (please specify): | ||||
| 3. Full name of person(s) subject to the notification obligation: iii |
IP Group plc | |||
| 4. Full name of shareholder(s) (if different from 3.):iv | See section 9 | |||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v |
19 May 2015 | |||
| 6. Date on which issuer notified: | 20 May 2015 | |||
| 7. Threshold(s) that is/are crossed or reached: vi, vii |
Direct interests: unchanged Indirect interests: Below 3% Combined direct and indirect interests: 14% reached |
|||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | ||||||||||||
| Direct xi | Indirect xii | Direct | Indirect | |||||||||||||
| Ordinary 0.5p Shares | 127,837,566 | 127,837,566 | 110,837,566 | 103,042,836 | 7,794,730 | 13.56% | 1.03% | |||||||||
| GB00B5SGVL29 | ||||||||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| Nominal | Delta | |||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 110,837,566 | 14.59% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||||||||||||||||
| Direct interests: Techtran Group Limited - 103,042,836 Techtran Group Limited is a 100% owned subsidiary of IP Group plc. Indirect interests: IP Venture Fund - 7,794,730 IP Venture Fund is a limited partnership fund that is managed by Top Technology Ventures Limited, a 100% subsidiary of IP Group plc. |
||||||||||||||||
| Proxy Voting: | ||||||||||||||||
| 10. Name of the proxy holder: | ||||||||||||||||
| 11. Number of voting rights proxy holder will cease to hold: |
||||||||||||||||
| 12. Date on which proxy holder will cease to hold voting rights: |
||||||||||||||||
| 13. Additional information: | This notification relates to reductions in the holdings in the issuer by IP Venture Fund. IP Group's direct holdings are unchanged. Based on 759,653,093 Ordinary Shares in issue |
|||||||||||||||
| 14. Contact name: | Greg Smith | |||||||||||||||
| 15. Contact telephone number: | 020 7444 0050 | |||||||||||||||
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUASWRVNAVURR
More from TISSUE REGENIX GROUP PLC
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 7
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 22
Regulatory Filings
2025
Dec 8
Regulatory Filings
2025
Dec 4
Capital/Financing Update
2025
Dec 1
Capital/Financing Update
2025
Nov 7
Delisting Announcement
2025
Oct 22
Board/Management Information
2025
Oct 17